Matches in Nanopublications for { ?s ?p "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP892736.RAaIZPDFZv3zazsDII5xABxUnh6oOJR0nb83LNp5ULDuE130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892736.RAaIZPDFZv3zazsDII5xABxUnh6oOJR0nb83LNp5ULDuE130_provenance.
- assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_provenance.
- NP578596.RANja6xOkvxI3zJTOuVw63-66ZOR_pxKQ6ny-QMglx_II130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578596.RANja6xOkvxI3zJTOuVw63-66ZOR_pxKQ6ny-QMglx_II130_provenance.